stockrowNovaBridge Biosciences (NBP) vs Outlook Therapeutics, Inc. (OTLK)
- NovaBridge Biosciences NBP 0.90 −1.10%
- Outlook Therapeutics, Inc. OTLK 0.43 −2.27%
NovaBridge Biosciences and Outlook Therapeutics, Inc. are both Biotechnology companies. NovaBridge Biosciences and Outlook Therapeutics, Inc. are of similar size ($106.9M and $105.3M). NovaBridge Biosciences grew revenue faster over the last twelve months: −91.8% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Outlook Therapeutics, Inc. leads on 11 and NovaBridge Biosciences on 4.
Valuation
Profitability
| Metric | NBP | OTLK | Biotechnology median |
|---|---|---|---|
| Gross margin | 31.10% | 195.62% | 68.51% |
| Operating margin | 0.00% | 4,781.76% | 0.00% |
| Net margin | 0.00% | 5,253.40% | 0.00% |
| Free cash flow margin | 0.00% | 4,826.38% | 0.00% |
| Return on equity | 0.00% | 256.92% | (51.96%) |
| Return on assets | 0.00% | (251.66%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack